Filing Details
- Accession Number:
- 0001209191-22-018885
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-15 17:14:35
- Reporting Period:
- 2022-03-14
- Accepted Time:
- 2022-03-15 17:14:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1707502 | Solid Biosciences Inc. | SLDB | Biological Products, (No Disgnostic Substances) (2836) | 900943402 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1727571 | Ashley Carl Morris | C/O Solid Biosciences Inc. 141 Portland Street, Fifth Floor Cambridge MA 02139 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-03-14 | 11,269 | $1.10 | 266,605 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-03-14 | 11,396 | $1.10 | 255,209 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
- Includes 2,272 shares acquired by Mr. Morris under the Solid Biosciences Employee Stock Purchase Plan on November 30, 2021.